Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,245 | 625 | 99.8% |
| Education | $21.15 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,631 | 87 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,031 | 68 | $0 (2024) |
| ABBVIE INC. | $835.76 | 42 | $0 (2024) |
| PFIZER INC. | $702.63 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $630.64 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $494.68 | 34 | $0 (2021) |
| UCB, Inc. | $402.05 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $332.11 | 33 | $0 (2020) |
| Lilly USA, LLC | $325.44 | 23 | $0 (2024) |
| Novo Nordisk Inc | $317.00 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,053 | 102 | ABBVIE INC. ($339.62) |
| 2023 | $1,361 | 72 | Amgen Inc. ($258.55) |
| 2022 | $391.64 | 23 | GlaxoSmithKline, LLC. ($68.14) |
| 2021 | $929.61 | 56 | GlaxoSmithKline, LLC. ($171.44) |
| 2020 | $698.34 | 42 | AbbVie Inc. ($134.56) |
| 2019 | $1,751 | 117 | Amgen Inc. ($397.37) |
| 2018 | $1,673 | 109 | Amgen Inc. ($359.27) |
| 2017 | $1,409 | 108 | GlaxoSmithKline, LLC. ($220.43) |
All Payment Transactions
629 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Diabetes Care | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Biological | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Immunology | ||||||
| 10/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: VACCINES | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.23 | General |
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Biosimilars | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,504 | 4,150 | $398,036 | $186,459 |
| 2022 | 16 | 1,541 | 1,740 | $277,468 | $126,253 |
| 2021 | 46 | 4,094 | 5,487 | $449,610 | $186,995 |
| 2020 | 54 | 6,429 | 8,573 | $595,572 | $192,292 |
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 23 | 2,460 | $79,980 | $45,076 | 56.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 423 | 555 | $102,654 | $42,582 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 272 | 318 | $79,932 | $35,603 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 261 | 261 | $66,537 | $31,174 | 46.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 38 | 38 | $20,322 | $10,663 | 52.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 117 | 117 | $15,849 | $8,406 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 120 | 120 | $6,117 | $3,340 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 54 | $6,440 | $2,493 | 38.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,405 | $1,991 | 45.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 47 | 47 | $2,361 | $1,308 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,992 | $1,003 | 33.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 23 | $2,829 | $841.06 | 29.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 38 | 38 | $1,786 | $577.80 | 32.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 50 | $2,500 | $433.44 | 17.3% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 11 | 11 | $1,100 | $408.21 | 37.1% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 11 | 11 | $904.00 | $262.27 | 29.0% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 11 | 12 | $756.00 | $195.19 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $572.00 | $104.50 | 18.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 284 | 347 | $83,280 | $38,770 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 407 | 518 | $92,204 | $35,412 | 38.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 166 | 168 | $18,990 | $11,482 | 60.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $21,068 | $11,227 | 53.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 30 | 30 | $15,870 | $8,319 | 52.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 170 | 172 | $8,600 | $4,526 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 81 | $9,558 | $4,192 | 43.9% |
About Dr. Douglas Eddy, M.D
Dr. Douglas Eddy, M.D is a Internal Medicine healthcare provider based in Rogers, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982961124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Eddy, M.D has received a total of $10,266 in payments from pharmaceutical and medical device companies, with $2,053 received in 2024. These payments were reported across 629 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,245).
As a Medicare-enrolled provider, Eddy has provided services to 13,568 Medicare beneficiaries, totaling 19,950 services with total Medicare billing of $691,999. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Rogers, AR
- Active Since 04/12/2012
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982961124
Products in Payments
- Enbrel (Biological) $630.34
- TRELEGY ELLIPTA (Drug) $456.94
- Cimzia (Drug) $385.77
- EVENITY (Biological) $376.70
- RINVOQ (Biological) $368.38
- SIMPONI ARIA (Biological) $347.99
- XIFAXAN (Drug) $298.77
- BENLYSTA (Biological) $293.16
- FARXIGA (Drug) $284.82
- Otezla (Drug) $279.50
- XARELTO (Drug) $274.02
- BREZTRI (Drug) $250.56
- FREESTYLE LIBRE (Device) $247.38
- Prolia (Biological) $219.25
- ELIQUIS (Drug) $219.23
- COSENTYX (Biological) $186.50
- PREVNAR 20 (Biological) $148.41
- TALTZ (Drug) $148.20
- Livalo (Drug) $147.04
- Ozempic (Drug) $142.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rogers
Dr. Daniel Paul, Md, MD
Internal Medicine — Payments: $228,685
Stuart Benson, D.o, D.O
Internal Medicine — Payments: $39,908
Dr. Kiran Kurichety, Md, MD
Internal Medicine — Payments: $15,406
Lance Weathers, Md, MD
Internal Medicine — Payments: $10,694
Dr. Michael Garone, D.o, D.O
Internal Medicine — Payments: $5,985
James Baker, Do, DO
Internal Medicine — Payments: $5,557